logo
Wyślij wiadomość

High Purity GS-441524 Antiviral API for FIP Treatment with Stable Structure and Controlled Production

10 fiolek
MOQ
US$20/vial-US$30/vial
Cena £
High Purity GS-441524 Antiviral API for FIP Treatment with Stable Structure and Controlled Production
cechy Galeria opis produktu Poprosić o wycenę
cechy
specyfikacje
Nazwa produktu: GS-441524
Opakowanie: 6 ml, 8 ml, 10 ml
Formularz dawkowania: Zastrzyk
CAS: 1191237-69-0
Droga administracji: Wstrzyknięcie podskórne
Wytrzymałość: 20 mg, 30 mg
Kraj produkcji: Chiny
Pochodzenie: Chiny
Funkcjonować: Leczenie FIP u kotów
Sposób wysyłki: FedEx/UPS/DHL
Podkreślić:

High Purity GS-441524

,

Stable Structure FIP Treatment

,

Controlled Production Antiviral API

Podstawowe informacje
Miejsce pochodzenia: Chiny
Nazwa handlowa: LongilatBio
Zapłata
Szczegóły pakowania: 10 fiolek/pudełko
Czas dostawy: 2-3 dni
Zasady płatności: L/C, D/A, D/P, T/T, Western Union, 速汇金
Możliwość Supply: 100, 000 fiolki na miesiąc
opis produktu
High Purity GS-441524 Antiviral Research API
Stable Structure Controlled Production
Product Introduction
GS-441524 is a nucleoside analog compound commonly referenced in feline infectious peritonitis (FIP) management programs. In veterinary settings, it is supplied as an injectable solution and applied under professional supervision.
The injectable format allows systemic absorption and is often selected in situations where stable and predictable dosing is required during FIP support protocols.
Product Specifications
ItemDetails
Product NameGS-441524
CAS Number1191237-69-0
Dosage FormInjection
Strength20mg / 30mg
Packaging6ml / vial, 8ml / vial, 10ml / vial
Storage ConditionRoom Temperature
Expiry Date1 Year from Date of Manufacture
Country of ManufactureChina
IndicationManagement Support for Cat FIP
Each vial is labeled with batch number and manufacturing date for traceability.
High Purity GS-441524 Antiviral API for FIP Treatment with Stable Structure and Controlled Production 0
About Feline Infectious Peritonitis (FIP)
Feline Infectious Peritonitis (FIP) is a progressive viral disease caused by mutation of feline coronavirus. It typically presents as:
  • Wet (Effusive) FIP
  • Dry (Non-effusive) FIP
  • Ocular involvement
  • Neurological involvement
Different clinical forms may require different dosage considerations.
Reference Dosage Guidelines
Dosage should be determined by a licensed veterinarian based on body weight and clinical status.
Common reference protocols:
  • FIP (Wet): 0.3 ml × body weight (kg) + 0.1 ml residue
  • FIP (Dry): 0.4 ml × body weight (kg) + 0.1 ml residue
  • Eye / Nerve Involvement: 0.5 ml × body weight (kg) + 0.1 ml residue
  • Recurrence Cases: 0.6 ml × body weight (kg) + 0.1 ml residue
Body weight should be monitored regularly during the treatment cycle.
Product Characteristics
  • Injectable systemic delivery
  • Two concentration options (20mg / 30mg)
  • Room temperature storage
  • Multiple vial sizes available
  • Clear labeling and batch tracking
The formulation is prepared to maintain stability within recommended storage conditions for up to one year.
Packaging & Handling
Each vial is sealed to minimize contamination risk.
Store in a dry environment at room temperature. Avoid prolonged light exposure.
Important Notice
For veterinary use only.
Treatment plans should be determined by qualified professionals in accordance with local regulations.
Polecane produkty
Skontaktuj się z nami
Osoba kontaktowa : Mrs. Nancylee
Tel : +86 15508667508
Pozostało znaków(20/3000)